Acceptance of Evidence Transfer Within German Early Benefit Assessment of New Drugs for Pediatric and Adolescents Target Populations.
Saved in:
| Title: | Acceptance of Evidence Transfer Within German Early Benefit Assessment of New Drugs for Pediatric and Adolescents Target Populations. |
|---|---|
| Authors: | Pick G; Institute of Health Economics and Clinical Epidemiology, Medical Faculty, University of Cologne, Cologne, Germany., Müller D; Institute of Health Economics and Clinical Epidemiology, Medical Faculty, University of Cologne, Cologne, Germany., Dintsios CM; Institute for Health Services Research and Health Economics, Centre for Health and Society, Medical Faculty, Heinrich Heine University, Building: 12.49, Moorenstr. 5, 40225, Düsseldorf, Germany. dintsios@hhu.de. |
| Source: | PharmacoEconomics [Pharmacoeconomics] 2025 May; Vol. 43 (5), pp. 521-553. Date of Electronic Publication: 2025 Jan 17. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1179-2027 |
|---|---|
| DOI: | 10.1007/s40273-024-01467-8 |
